Hyaluronic acid and cancer
- Hyaluronic acid and cancer
- Brave beauty in the face of cancer: skincare | sephora
- Hyaluronic acid (ha); 7 proven anti-aging benefits
- The intersection of hyaluronic acid injection: cases
- Hyaluronic acid supplement benefits | research
- A dermatologist explains the benefits of hyaluronic acid
- New vitamin c + hyaluronic acid serum for bright, glowing
Brave beauty in the face of cancer: skincare | sephora
Background information Hyaluronic acid (HA) has long been used as a key component of nanocarriers for cancer imaging and treatment. At physiological pH, HA has both hydrophilic and anionic properties, and its molecular weight has an effect on its physicochemical and mechanical properties. Several preparation methods may be used to transform HA or HA derivatives into nanocarriers with other usable materials, drug cargos, and imaging agents. Furthermore, its biocompatibility and biodegradability could increase its clinical application feasibility. Covered area This study summarizes the physicochemical and biological properties of HA. Various forms of HA nanosystems can be engineered for CD44 receptor-positive cancer imaging and therapy based on those properties. Recent advances in HA-drug conjugates, HA-based nanoparticles (NPs), and HA-decorated nanoparticles (NPs) for cancer imaging and therapy are discussed. Expert advice Expandability in chemical modification of HA and fabrication of HA-based nanosystems can increase their clinical application potential, in addition to their well-known biocompatibility/biodegradability and CD44 receptor-positive tumor targetability.
Hyaluronic acid (ha); 7 proven anti-aging benefits
Hyaluronic acid, once an unpronounceable term that no one had heard of, is now all the rage and appears in almost every beauty product on the market. But do you really understand what it is and how it can help you?
Dr. Robert Skaggs of Kentucky Skin Cancer Center claims that knowledge and awareness are the most important parts of every care you receive. He will answer all of your questions regarding this effective ingredient. The more information you have, the better equipped you will be to make choices that are best for your wellbeing and appearance.
Let’s describe hyaluronic acid just to make sure we’re all on the same page (HA). HA is a naturally occurring material that acts as a lubricant in your eyes and joints. It does, however, play an important role in the protection of your skin! Dr. Skaggs, a board-certified dermatologist, is particularly interested in HA because of its skin-beneficial properties.
Hyaluronic acid, like a sponge, can hold 1,000 times its own weight in water. You may have noticed the word “humectant” on the label of your lotion — HA is one of the best humectants available. When HA comes into contact with your skin, it attaches water to your skin cells, keeping your skin hydrated.
The intersection of hyaluronic acid injection: cases
The bioactive activity of hyaluronic acid (HA) during carcinogenesis has been observed in recent laboratory studies on human cancer diseases. The extracellular matrix contains HA as a part (ECM). It has a strong link to tumor cell proliferation, metastasis, and development. The aim of this study was to assess the biochemical function of HA, as well as its degrading enzymes and products, in breast cancer (BC) patients undergoing therapy.
Standard spectrophotometric techniques were used to estimate the activities of HA degrading enzymes hyaluronidase (HAS), N-acetyl-beta-D-glucosminidase (NAG), and beta-glucuronidase (beta-Glu), as well as the concentrations of both glucoseamine (G-Amine) and glucuronic acid (GA) as degrading products in the blood sera of 50 BC patients before and after A computational software for social sciences was used to conduct the analyses (SPSS, version 15.0).
Hyaluronic acid supplement benefits | research
Download the bibliography
A dermatologist explains the benefits of hyaluronic acid
Thank You Notes
New vitamin c + hyaluronic acid serum for bright, glowing
While working with Prof. Linda Pilarski, I produced some of the plasmids used in this analysis (University of Alberta, Canada). Prof. Pilarski also provides technical assistance. Dr. Steve Lewis and Dr. Michael Wall provided critical feedback on the manuscript, which we appreciate. We also appreciate the financial support from the New Brunswick Health Research Foundation.
The research grants were funded by the New Brunswick Health Research Foundation. The funding body has no involvement in the study design, data collection, examination, and interpretation, or manuscript writing.
(A) The cells expressing HAS1 (lower panels) had a larger Golgi apparatus than the control pTET cells (upper panels). The Golgi bodies (GM130, green), centrosome (pericentrin, red), and nucleus (blue) in the first panel, HA (white) in the second panel, and DIC image of the cell structure in the third panel were stained for the tetracycline-inducible DLD1 cells with HAS1 and control (pTET) as defined in Fig. 5B. (B) The coordinated cells at mitosis and the G1/S step of the cell cycle are indicated by the respective cell populations. Double thymidine blocks were used to synchronize transfected HeLa cells. Flow cytometry was used to check for synchronization by measuring the DNA content of the cells. To determine the amount of DNA in cell populations, the cells were harvested, fixed in cold ethanol, and stained with propidium iodide. (158 kb PDF) Permissions and rights